Aldosterone, Subclinical Cardiac Dysfunction, and Heart Failure Subtypes: The Jackson Heart Study
- PMID: 41037836
- DOI: 10.1016/j.jchf.2025.102670
Aldosterone, Subclinical Cardiac Dysfunction, and Heart Failure Subtypes: The Jackson Heart Study
Keywords: aldosterone; heart failure; heart failure type; renin-angiotensin-aldosterone system.
Conflict of interest statement
Funding Support and Author Disclosures The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the U.S. Department of Health and Human Services. The Jackson Heart Study is supported and conducted in collaboration with Jackson State University (HHSN268201800013I), Tougaloo College (HHSN268201800014I), the Mississippi State Department of Health (HHSN268201800015I) and the University of Mississippi Medical Center (HHSN268201800010I, HHSN268201800011I and HHSN268201800012I) contracts from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Minority Health and Health Disparities (NIMHD). Dr Echouffo-Tcheugui is funded by NIH/NHLBI grant K23 HL153774; and has received research funding from Bayer. Dr Berry has received grant support from the NIH (grants R01HL159994, K24 HL166681), and the Center for Clinical and Translational Sciences (UL1TR003167); has received prior grant support from Roche Diagnostics and Abbott Diagnostics; and has received consulting income from the Cooper Institute. All other authors have reported that they have no relationships relative to the content of this paper to disclose.
LinkOut - more resources
Full Text Sources